Merck, 1072221000, Peracetic acid about 38-40%

Application

Development of the radiosynthesis of high-specific-activity 123I-NKJ64.: This study by Tavares et al. (2011) presents the development and optimization of the radiosynthesis of high-specific-activity 123I-NKJ64, a compound used in nuclear medicine. The synthesis process involved the use of 38% peracetic acid as a key reagent to achieve the desired radioisotope incorporation and purity. This research highlights the importance of peracetic acid in the production of radiopharmaceuticals, demonstrating its role in enhancing the efficiency and effectiveness of radiosynthetic procedures (Tavares et al., 2011).

Analysis Note
Assay (peracetic acid)37.5 - 40.5 %Identity (IR-spectrum)passes test

Date of expiry: see product label
Disclaimer
The product is not intended for use as a biocide under global biocide regulations, including but not limited to US EPA′s Federal Insecticide Fungicide and Rodenticide Act, European Biocidal Products Regulation, Canada’s Pest Management Regulatory Agency, Turkey’s Biocidal Products Regulation, Korea’s Consumer Chemical Products and Biocide Safety Management Act (K-BPR) and others.